Atorvastatin Calcium Tablet
Product Images NDC 71335-2404

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 71335-2404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 01)

Chemical structure of atorvastatin calcium, showing its molecular configuration including phenyl groups, fluorophenyl group, hydroxyl groups, and associated calcium ions with hydration.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 02)

A line graph depicting cumulative incidence (%) over a period of 3.5 years comparing Atorvastatin with Placebo. The solid line represents Atorvastatin, while the dashed line represents Placebo, with Atorvastatin showing consistently lower cumulative incidence. The graph includes hazard ratio (HR=0.64) and a p-value (p=0.0005).*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 03)

A line graph displaying cumulative hazard percentage over five years, comparing Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint through four years of follow-up, while the y-axis shows cumulative hazard percentage. Atorvastatin shows a consistently lower cumulative hazard than placebo, with a hazard ratio (HR) of 0.63 and p-value of 0.001 indicated on the graph.*

FDA Label Image

Image (3ce77d64 B08e 43b6 A3ab 3aca688f734a 04)

A line graph displaying the percentage of subjects experiencing a major cardiovascular event over time, comparing Atorvastatin 10 mg and Atorvastatin 80 mg dosages. The x-axis represents time to first event in years (0 to 5), and the y-axis shows the percentage of subjects affected. The graph includes hazard ratio (HR 0.78) with confidence interval and p-value data.*

FDA Label Image

Label (Lbl713352404)

Atorvastatin Calcium 20 mg film-coated tablets label shows the drug's NDC 71335-2404-1. The label states each tablet contains atorvastatin calcium equivalent to 20 mg of atorvastatin. It indicates a package of 30 tablets, repackaged by Bryant Ranch Prepack, Inc. and manufactured by Graviti Pharmaceuticals Pvt. Ltd. Storage instructions and safety warnings are also included.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.